Molecule
Centruroides fab2 antivenin (equine) is an antivenin indicated for the treatment of clinical signs of scorpion envenomation. It is available as powder for injection for intravenous use. MedsAcross supplies Centruroides fab2 antivenin (equine) for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
ANASCORP is an antivenin indicated for the treatment of clinical signs of scorpion envenomation. ANASCORP® [centruroides (scorpion) immune F(ab') 2 (equine) injection] is an equine-derived antivenom indicated for treatment of patients with clinical signs of scorpion envenomation.
Source: US FDA prescribing information
ANASCORP is composed of venom-specific F(ab') 2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body. 1
Source: US FDA prescribing information
Intravenous use only. Initial Dose 3 vials Reconstitute each vial with 5 milliliters of sterile normal saline (0.9% NaCl). Combine and further dilute to a total of 50 milliliters. Infuse intravenously over 10 minutes. Additional dose (s) As needed Administer one vial at a time at 30-60 minute intervals. Dilute to a total of 50 milliliters with sterile normal saline (0.9% NaCl). Initiate treatment with ANASCORP as soon as possible after scorpion sting in patients who develop clinically important signs of scorpion envenomation, including but not limited to loss of muscle control, roving or abnormal eye movements, slurred speech, respiratory distress, excessive salivation, frothing at the mouth, vomiting. Close patient monitoring is necessary. For Intravenous use only.
Source: US FDA prescribing information
None. None.
Source: US FDA prescribing information
Severe hypersensitivity reactions, including anaphylaxis, are possible with ANASCORP. Prepare for monitoring and management of allergic reactions, particularly in patients with a history of hypersensitivity to equine (horse) proteins or patients who have received previous therapy with antivenoms containing scorpion or equine proteins. Delayed allergic reactions (serum sickness) may occur following treatment with ANASCORP. Patient monitoring with follow-up visit is recommended. ANASCORP is made from equine plasma and may contain infectious agents, e.g. viruses. Localized reactions and generalized myalgias have been reported with the use of cresol as an injectable excipient.
Source: US FDA prescribing information
The most common adverse reactions observed in ≥ 2% of patients in the clinical studies for ANASCORP were: vomiting, pyrexia, rash, nausea and pruritus.
Source: US FDA prescribing information
No drug interaction studies have been conducted with ANASCORP.
Source: US FDA prescribing information
Store at room temperature (up to 25 ºC (77 ºF)). Brief temperature excursions are permitted up to 40 ºC (104ºF). DO NOT FREEZE.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Centruroides fab2 antivenin (equine), sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Anascorp 7 mg/mL powder for injectionIntravenous | Rare Disease Therapeutics | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 1 presentations of Centruroides fab2 antivenin (equine) and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Centruroides fab2 antivenin (equine), including Anascorp.
No listed presentation of Centruroides fab2 antivenin (equine) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.